UNH vs GILD
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Gilead Sciences, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | GILD |
|---|---|---|
| Price | $418.09 | $156.04 |
| Market cap | $375.28B | $193.48B |
| P/E ratio | 26.9 | — |
| ROE | 15.77% | -20.68% |
| Profit margin | 3.53% | -10.64% |
| Revenue growth | -0.40% | 10.20% |
| Dividend yield | 2.22% | 2.10% |
| Beta | 0.61 | 0.33 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs GILD in plain English
- UNH is the bigger company — about 1.9× the market cap of GILD.
- UNH earns a higher return on equity (16% vs -21%).
- GILD is growing revenue faster (10% vs -0%).
- UNH has the higher dividend yield (2.22% vs 2.10%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
GILD return calculator
See what $1,000 in Gilead Sciences, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.